Treatment of Immune-Mediated TTP (iTTP) at First Acute Event

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) presenting as a first acute event requires prompt, protocol-driven management. Evidence-based guidance addresses this specific presentation directly.

Clinical scenario: A patient with immune-mediated thrombotic thrombocytopenic purpura (iTTP) experiencing a first acute event.

Treatment approach

The recommended first-line approach centres on therapeutic plasma exchange (TPE) combined with an additional intervention — the full combination and protocol details are available in the complete structured regimen.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/jth.15010

For patients with iTTP experiencing a first acute event, the panel recommends the addition of corticosteroids to therapeutic plasma exchange (TPE) over TPE alone.

View source ↗